{
    "medicine_id": "d4f4f76de4f3b3304a07e025d24926be0784b005",
    "platform_id": "DB05452",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v PH 284",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in anorexia and other conditions causing harmful weight loss The manufacturer suggests it could be relevant for treatment of weight loss and the associated symptoms i e lack of energy decrease in appetite physical wasting vulnerability to toxicity and sometimes reduced life expectancy in patients with eating disorders patients with advanced cancer patients with AIDS and patients experiencing loss of appetite due to aging acute illness or pregnancy",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Vomeropherins are self administered by the patient with a metered nasal spray or nasal aerosol device so that they can bind to peripheral chemosensory receptors in the nasal passages This binding produces neural impulses that are transmitted by specific pathways to the hypothalamic centre that directly and rapidly affect brain function",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}